MUSOLINO, GIUSEPPE ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 197
EU - Europa 75
AS - Asia 73
SA - Sud America 8
AF - Africa 2
Totale 355
Nazione #
US - Stati Uniti d'America 196
SG - Singapore 24
DE - Germania 22
CN - Cina 16
HK - Hong Kong 10
RU - Federazione Russa 10
VN - Vietnam 10
GB - Regno Unito 7
IT - Italia 7
SE - Svezia 7
BR - Brasile 6
TR - Turchia 6
UA - Ucraina 5
FI - Finlandia 4
FR - Francia 4
BG - Bulgaria 3
CO - Colombia 2
IE - Irlanda 2
IN - India 2
MA - Marocco 2
NL - Olanda 2
ES - Italia 1
GE - Georgia 1
IQ - Iraq 1
KR - Corea 1
KW - Kuwait 1
MX - Messico 1
PK - Pakistan 1
PL - Polonia 1
Totale 355
Città #
Ashburn 26
Chandler 23
Fairfield 23
Woodbridge 15
Cambridge 11
Seattle 11
Singapore 11
Hong Kong 10
San Jose 10
Wilmington 9
Houston 8
Los Angeles 6
Beijing 5
Izmir 5
Dallas 4
Ho Chi Minh City 4
Jacksonville 4
Princeton 4
Santa Clara 4
Boardman 3
Frankfurt am Main 3
Hanoi 3
Lauterbourg 3
Munich 3
Sofia 3
Trieste 3
Ann Arbor 2
Casablanca 2
Chicago 2
Columbus 2
Dublin 2
Düsseldorf 2
Helsinki 2
Moscow 2
Norwalk 2
Alecrim 1
Baghdad 1
Belo Horizonte 1
Bogotá 1
Bozyazı 1
Brescia 1
Buffalo 1
Carney 1
Cartagena 1
Catalão 1
Centro 1
Chennai 1
Cholet 1
City of London 1
Fremont 1
Jacareí 1
Kuwait City 1
Marília 1
Milan 1
Nanjing 1
Nelson 1
Nuremberg 1
Orem 1
Portsmouth 1
Pune 1
Rio de Janeiro 1
Rome 1
Seoul 1
Shenzhen 1
Stockholm 1
Trotwood 1
Turku 1
Warsaw 1
Wuhan 1
Totale 266
Nome #
Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer 198
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 163
Totale 361
Categoria #
all - tutte 1.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.099


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 1 2
2021/202219 1 1 0 1 0 1 3 1 3 2 0 6
2022/202339 3 5 4 5 5 8 0 4 4 0 1 0
2023/202419 0 1 0 2 1 3 4 5 0 0 3 0
2024/202552 0 0 13 4 3 3 1 4 6 11 5 2
2025/202690 12 5 3 5 13 5 14 3 14 16 0 0
Totale 361